Preclinical Characterization of a Novel Monoclonal Antibody NEO-201 for the Treatment of Human Carcinomas

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2017.01899
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

A Novel Multipurpose Monoclonal Antibody for Evaluating Human C-Met Expression in Preclinical and Clinical Settings

Applied Immunohistochemistry and Molecular Morphology
Forensic MedicinePathologyMedical Laboratory TechnologyHistology
2009English

Characterization of a Monoclonal Antibody to Human Erythropoietin.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1982English

Characterization of a Monoclonal Antibody Specific for Human Active Renin

Hypertension
Internal Medicine
1992English

Development, Characterization, and Applications of a Novel Estrogen Receptor Beta Monoclonal Antibody

Journal of Cellular Biochemistry
BiochemistryCell BiologyMolecular Biology
2012English

Preclinical Characterization of Recombinant Human Tissue Kallikrein-1 as a Novel Treatment for Type 2 Diabetes Mellitus

PLoS ONE
Multidisciplinary
2014English

Characterization of the cDNA of a Broadly Reactive Neutralizing Human Anti-Gp120 Monoclonal Antibody.

Journal of Clinical Investigation
Medicine
1992English

Human Monoclonal Antibody-Based Therapy in the Treatment of Invasive Candidiasis

Clinical and Developmental Immunology
2013English

Characterization of an Antagonist Monoclonal Antibody, GHBP116, Specific for Human Growth Hormone Receptors.

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
1999English

C595 – A Monoclonal Antibody Against the Protein Core of Human Urinary Epithelial Mucin Commonly Expressed in Breast Carcinomas

British Journal of Cancer
Cancer ResearchOncology
1990English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy